Participating in a COVID-19 Vaccine Trial

By: Amelia Gibson, PhD, MBA, Senior Director of Product Licensing at Kerafast and Absolute Antibody It’s rare that one gets to participate in something as historic and globally impactful as the development of a COVID-19 vaccine. While I know little about vaccine development and no longer do any benchwork, I knew that I could contribute 

Continue Reading…

10 Unique Reagents that Helped Advance Research in 2020

Here at Kerafast, our company mission is to facilitate access to unique reagents developed by academic laboratories worldwide on behalf of the scientific community. Together with our providing investigators, we work to distribute reagents that might otherwise have been sitting unused in laboratory freezers to researchers committed to furthering scientific progress. The COVID-19 outbreak made 

Continue Reading…

Kerafast Recognized by BioNTech for Support in Developing a COVID-19 Vaccine

BioNTech recently published an announcement expressing gratitude to its employees and various partners who have assisted the company in developing a successful COVID-19 vaccine. The BioNTech-Pfizer vaccine has been shown to be 95% effective in preventing COVID-19 and it has received emergency use authorizations from more than 45 countries around the world. Kerafast is very 

Continue Reading…